Molly® Modular Platform Autoinjector

Molly is a single-dose autoinjector technology developed to help pharma and biotech companies reduce initial investments and expedite development timelines. Built on a proven modular platform, Molly reduces risks during the development process while increasing flexibility in device design and production. Available in 1.0 mL and 2.25 mL variations, products using Molly autoinjectors have been approved and launched in 14 molecular entities covering at least 25 clinical indications in a variety of standard and customized designs around the world. For more information, go to: https://molly.shl-medical.com/